lixte biotechnology holdings
Transactions by LIXTE BIOTECHNOLOGY HOLDINGS (LIXT) in the last 6 months
Lixte Biotechnology Holdings, Inc. (OTCPK:LIXT) announced a private placement of convertible preferred stock for gross proceeds of $1,750,000 with one of its major shareholders on March 18, 2015. The preferred shares are convertible into 2,187,500 common shares at $0.80 per share.
|No competitor information is available for LIXT.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|